We previously identified an allo-restricted CD8α-dependent Vγ5Vδ1TCR clone FE11 (28), which showed in vitro antitumor reactivity against HLA-A*24:02-expressing tumor cells (34). This evidence concerns the gene CD8A and neoplasm.